Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
Extracellular vesicles (EVs) are cell‐derived nanosized vesicles that mediate cell‐to‐cell communication via transporting bioactive molecules and thus are critically involved in various physiological and pathological conditions. EVs contribute to different aspects of cancer progression, such as cancer growth, angiogenesis, metastasis, immune evasion, and drug resistance. EVs induce the resistance of cancer cells to chemotherapy, radiotherapy, targeted therapy, antiangiogenesis therapy, and immunotherapy by transferring specific cargos that affect drug efflux and regulate signaling pathways associated with epithelial‐mesenchymal transition, autophagy, metabolism, and cancer stemness. In addition, EVs modulate the reciprocal interaction between cancer cells and noncancer cells in the tumor microenvironment (TME) to develop therapy resistance. EVs are detectable in many biofluids of cancer patients, and thus are regarded as novel biomarkers for monitoring therapy response and predicting prognosis. Moreover, EVs are suggested as promising targets and engineered as nanovehicles to deliver drugs for overcoming drug resistance in cancer therapy. In this review, the biological roles of EVs and their mechanisms of action in cancer drug resistance are summarized. The preclinical studies on using EVs in monitoring and overcoming cancer drug resistance are also discussed.
Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
Extracellular vesicles (EVs) are cell‐derived nanosized vesicles that mediate cell‐to‐cell communication via transporting bioactive molecules and thus are critically involved in various physiological and pathological conditions. EVs contribute to different aspects of cancer progression, such as cancer growth, angiogenesis, metastasis, immune evasion, and drug resistance. EVs induce the resistance of cancer cells to chemotherapy, radiotherapy, targeted therapy, antiangiogenesis therapy, and immunotherapy by transferring specific cargos that affect drug efflux and regulate signaling pathways associated with epithelial‐mesenchymal transition, autophagy, metabolism, and cancer stemness. In addition, EVs modulate the reciprocal interaction between cancer cells and noncancer cells in the tumor microenvironment (TME) to develop therapy resistance. EVs are detectable in many biofluids of cancer patients, and thus are regarded as novel biomarkers for monitoring therapy response and predicting prognosis. Moreover, EVs are suggested as promising targets and engineered as nanovehicles to deliver drugs for overcoming drug resistance in cancer therapy. In this review, the biological roles of EVs and their mechanisms of action in cancer drug resistance are summarized. The preclinical studies on using EVs in monitoring and overcoming cancer drug resistance are also discussed.
Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
Yang, Qiurong (Autor:in) / Xu, Jing (Autor:in) / Gu, Jianmei (Autor:in) / Shi, Hui (Autor:in) / Zhang, Jiayin (Autor:in) / Zhang, Jianye (Autor:in) / Chen, Zhe‐Sheng (Autor:in) / Fang, Xinjian (Autor:in) / Zhu, Taofeng (Autor:in) / Zhang, Xu (Autor:in)
Advanced Science ; 9
01.12.2022
33 pages
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
| Wiley | 2019
| Wiley | 2023
Extracellular Vesicles Mediate the Intercellular Exchange of Nanoparticles
| Wiley | 2022
Microenvironmental Modulation for Therapeutic Efficacy of Extracellular Vesicles
| Wiley | 2025